Janesville-based SHINE Technologies announced today a conditional commitment from the U.S. Department of Energy (DOE) to provide a $263... SHINE Technologies has raised $240 million in a funding round ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Janesville-based nuclear fusion technology company SHINE ...
Collaboration enables access to SHINE’s supply of lutetium-177 for Nucleus RadioPharma’s radioligand therapy for neuroendocrine tumors and prostate cancer ROCHESTER, Minn. & JANESVILLE, ...
JANESVILLE—SHINE Technologies is getting another multimillion-dollar financial boost in its quest to reach commercial production of nuclear medicines in Janesville. According to an announcement by the ...
SHINE Medical Technologies has landed $80 million in financing the company says will help it commercialize radioisotopes it plans to produce for medical testing and cancer therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results